Coronary vasospasm and the regulation of coronary blood flow

Progress in Cardiovascular Diseases

Volumn 46, Issue 4, 2004, Pages 349-373

  Konidala, Srilakshmi ^a   Gutterman, David D ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REACTIVE OXYGEN METABOLITE;

ACUTE HEART INFARCTION; ALLERGIC REACTION; ARTERY ENDOTHELIUM; CLINICAL FEATURE; COCAINE DEPENDENCE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY SPASM; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE PREDISPOSITION; EXPERIMENTAL MODEL; FEMALE; HEART CATHETER; HUMAN; IATROGENIC DISEASE; PATHOPHYSIOLOGY; PRINZMETAL ANGINA PECTORIS; PROGNOSIS; REVIEW; SMOOTH MUSCLE CONTRACTILITY;

EID: 1042298991     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2003.10.001     Document Type: Article

References (276)

1. Feigl E.O. Coronary physiology. Physiol Rev. 63:1983;1-205.
2. Young M.A., Vatner S.F. Regulation of large coronary arteries. Circ Res. 59:1986;579-596.
3. Britten M.B., Zeiher A.M., Schachinger V. Clinical importance of coronary endothelial vasodilator dysfunction and therapeutic options. J Intern Med. 245:1999;315-327.
4. Dusting G.J. Nitric oxide in coronary artery disease Roles in atherosclerosis, myocardial reperfusion and heart failure . EXS. 76:1996;33-55.
5. Marcus M.L. The coronary circulation in health and disease. 1983;McGraw-Hill, New York, NY.
6. Heistad D.D. What's new in the cerebral microcirculation? Microcirculation. 8:2001;365-375.
7. Guyton A.C., Langston J.B., Navar G. Theory for renal autoregulation by feedback at the juxtaglomerular apparatus. Circ Res. 14&15:1964;I187-I197.
8. Rivers R.J. Remote effects of pressure changes in arterioles. Am J Physiol. 268:1995;H1379-H1382.
9. Rivers R.J., Hein T.W., Zhang C., et al. Activation of barium-sensitive inward rectifier potassium channels mediates remote dilation of coronary arterioles. Circulation. 104:2001;1749-1753.
10. Mohrman D.E., Feigl E.O. Competition between sympathetic vasoconstriction and metabolic vasodilation in the canine coronary circulation. Circ Res. 42:1978;79-86.
11. Jackson C.V., Pope T.K., Lucchesi B.R. Coronary artery vasodilation in the canine Physiological and pharmacological roles of beta-adrenergic receptors . J Cardiovasc Pharmacol. 10:1987;196-204.
12. Gutterman D.D., Bonham A.C., Arthur J.M., et al. Characterization of coronary vasoconstrictor site in medullary reticular formation. Am J Physiol. 256:1989;H1218-H1227.
13. Shiode N., Morishima N., Nakayama K., et al. Flow-mediated vasodilation of human epicardial coronary arteries Effect of inhibition of nitric oxide synthesis . J Am Coll Cardiol. 27:1996;304-310.
14. Harrison D.G., Bates J.N. The nitrovasodilators New ideas about old drugs . Circulation. 87:1993;1461-1467.
15. Holtz J., Giesler M., Bassenge E. Two dilatory mechanisms of anti-anginal drugs on epicardial coronary arteries in vivo Indirect, flow-dependant, endothelium-mediated dilation and direct smooth muscle relaxation . Z Kardiol. 72:(Suppl 3):1983;98-106.
16. Downing S.E., Chen V. Dissociation of adenosine from metabolic regulation of coronary flow in the lamb. Am J Physiol. 251:1986;H40-H46.
17. Kroll K., Feigl E.O. Adenosine is unimportant in controlling coronary blood flow in unstressed dog hearts. Am J Physiol. 249:1985;H1176-H1187.
18. Kuo L., Chilian W.M., Davis M.J. Interaction of pressure- and flow-induced responses in porcine coronary resistance vessels. Am J Physiol. 261:1991;H1706-H1715.
19. Dube S., Canty J.M. Jr. Shear stress-induced vasodilation in porcine coronary conduit arteries is independent of nitric oxide release. Am J Physiol Heart Circ Physiol. 280:2001;H2581-H2590.
20. Kato M., Shiode N., Yamagata T., et al. Bradykinin induced dilatation of human epicardial and resistance coronary arteries in vivo Effect of inhibition of nitric oxide synthesis . Heart. 78:1997;493-498.
21. Miura H., Liu Y., Gutterman D.D. Human coronary arteriolar dilation to bradykinin depends on membrane hyperpolarization. Circulation. 99:1999;3132-3138.
22. Harrison D.G., Ohara Y. Physiologic consequences of increased vascular oxidant stresses in hypercholesterolemia and atherosclerosis Implications for impaired vasomotion . Am J Cardiol. 75:1995;75B-81B.
23. Mugge A., Elwell J.H., Peterson T.E., et al. Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. Circ Res. 69:1991;1293-1300.
24. Miura H., Wachtel R.E., Liu Y., et al. Flow-induced dilation of human coronary arterioles important role of Ca(2+)-activated K(+) channels . Circulation. 103:2001;1992-1998.
25. Dolezel S., Gerová M., Hartmannová B., et al. Development of the adrenergic innervation in the myocardium and coronary arteries of the dog. Acta Anat (Basel). 139:1990;191-200.
26. Armour J.A., Randall W.C. Functional anatomy of canine cardiac nerves. Acta Anat (Basel). 9:1975;510-528.
27. Blomquist T.M., Priola D.V., Romero A.M. Source of intrinsic innervation of canine ventricles A functional study . Am J Physiol. 252:1987;H638-H644.
28. Ito M., Zipes D.P. Efferent sympathetic and vagal innervation of the canine right ventricle. Circulation. 90:1994;1459-1468.
29. Gerová M., Barta E., Gero J. Sympathetic control of major coronary artery diameter in the dog. Circ Res. 44:1979;459-467.
30. Heusch G., Deussen A., Schipke J., et al. Alpha1-and alpha2-adrenoceptor- mediated vasoconstriction of large and small canine coronary arteries in vivo. J Card Pharmacol. 6:1984;961-968.
31. Kovach J.A., Gottdiener J.S., Verrier R.L. Vagal modulation of epicardial coronary artery size in dogs. A two-dimensional intravascular ultrasound study. Circulation. 92:1995;2291-2298.
32. Zeiher A.M., Drexler H., Wollschläger H., et al. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 83:1991;391-401.
33. Heusch G., Deussen A. The effects of cardiac sympathetic nerve stimulation on perfusion of stenotic coronary arteries in the dog. Circ Res. 53:1983;8-15.
34. Brown B.G., Lee A.B., Bolson E.L., et al. Reflex constriction of significant coronary stenosis as a mechanism contributing to ischemic left ventricular dysfunction during isometric exercise. Circulation. 70:1984;18-24.
35. Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 228:1980;373-376.
36. Muller J.M., Davis M.J., Kuo L., et al. Changes in coronary endothelial cell Ca2+ concentration during shear stress- and agonist-induced vasodilation. Am J Physiol. 276:1999;H1706-H1714.
37. Wellman G.C., Bonev A.D., Nelson M.T., et al. Gender differences in coronary artery diameter involve estrogen, nitric oxide, and Ca(2+)-dependent K+ channels. Circ Res. 79:1996;1024-1030.
38. Ferrer M., Marin J., Encabo A., et al. Role of K+ channels and sodium pump in the vasodilation induced by acetylcholine, nitric oxide, and cyclic GMP in the rabbit aorta. Gen Pharmacol. 33:1999;35-41.
39. Vanhoutte P.M. Endothelium-Derived Hyperpolarizing Factor. 1996;Academic Publishers, Amsterdam, Harwood.
40. Medhora M., Narayanan J., Harder D., et al. Identifying endothelium-derived hyperpolarizing factor Recent approaches to assay the role of epoxyeicosatrienoic acids . Jpn J Pharmacol. 86:2001;369-375.
41. Gauthier K.M., Deeter C., Krishna U.M., et al. 14,15-Epoxyeicosa-5(Z)- enoic acid A selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries . Circ Res. 90:2002;1028-1036.
42. Matoba T., Shimokawa H., Nakashima M., et al. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest. 106:2000;1521-1530.
43. Miura H., Bosnjak J.J., Ning G., et al. Role for hydrogen peroxide in flow-induced dilation of human coronary arterioles. Circ Res. 92:2003;e31-e40.
44. Iida Y., Katusic Z.S. Mechanisms of cerebral arterial relaxations to hydrogen peroxide. Stroke. 31:2000;2224-2230.
45. Vequaud P., Freslon J.L. Components of flow-induced dilation in rat perfused coronary artery. Cell Biol Toxicol. 12:1996;227-232.
46. Canty J.M. Jr, Schwartz J.S. Nitric oxide mediates flow-dependent epicardial coronary vasodilation to changes in pulse frequency but not mean flow in conscious dogs. Circulation. 89:1994;375-384.
47. Popp R., Fleming I., Busse R. Pulsatile stretch in coronary arteries elicits release of endothelium-derived hyperpolarizing factor A modulator of arterial compliance . Circ Res. 82:1998;696-703.
48. Kugiyama K., Ohgushi M., Motoyama T., et al. Nitric oxide-mediated flow-dependent dilation is impaired in coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol. 30:1997;920-926.
49. Graser T., Leisner H., Tiedt N. Absence of role of endothelium in the response of isolated porcine coronary arteries to acetylcholine. Cardiovasc Res. 20:1986;299-302.
50. Cowan C.L., McKenzie J.E. Cholinergic regulation of resting coronary blood flow in domestic swine. Am J Physiol. 259:1990;H109-H115.
51. Nakayama K., Osol G., Halpern W. Differential contractile responses of pressurized porcine coronary resistance-sized and conductance coronary arteries to acetylcholine, histamine and prostaglandin F2 alpha. Blood Vessels. 26:1989;235-245.
52. Drexler H., Zeiher A.M. Endothelial function in human coronary arteries in vivo. Hypertension. 18:1991;II-90-II-99.
53. Lefroy D.C., Crake T., Uren N.G., et al. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans. Circulation. 88:1993;43-54.
54. Nabel E.G., Selwyn A.P., Ganz P. Large coronary arteries in humans are responsive to changing blood flow An endothelium-dependent mechanism that fails in patients with atherosclerosis . J Am Coll Cardiol. 16:1990;349-356.
55. Miller F.J., Dellsperger K.C., Gutterman D.D. Pharmacologic activation of the human coronary microcirculation in vitro Endothelium-dependent dilation and differential responses to acetylcholine . Cardiovasc Res. 38:1998;744-750.
56. Heberden W. Commentaries on the history and cure of disease. Pectoris dolor. Willius F.A., Keys T.E. Cardiac Classics. 1802;Dover, New York.
57. Zoll P.M., Wessler S., Blumgart H.L. Angina pectoris A clinical and pathological correlation . Am J Med. 11:1951;331-357.
58. Chahine R.A., Luchi R.J. Coronary arterial spasm Culprit or bystander . Am J Cardiol. 37:1976;936-937.
59. Oliva P.B., Breckinridge J.C. Arteriographic evidence of coronary arterial spasm in acute myocardial infarction. Circulation. 56:1997;366-374.
60. Oliva P.B., Potts D.E., Pluss R.G. Coronary arterial spasm in Prinzmetal angina. N Engl J Med. 288:1973;745-787.
61. Maseri A., Pesola A., Marzilli M., et al. Coronary vasospasm in angina pectoris. Lancet. 1:1977;713-717.
62. Reddy K.G., Nair R.N., Sheehan H.M., et al. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol. 23:1994;833-843.
63. Bertrand M.E., Lablanche J.M., Tilmant P.Y., et al. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation. 65:1982;1299-1306.
64. Nakamura M., Tomoike H., Shimokawa H., et al. Coronary artery spasm in experimental animals. Abe H., et al. Regulation of Cardiac Function. 1984;261-265 Science Soc Press, Tokyo, Japan.
65. Teragawa H., Kato M., Kurokawa J., et al. Endothelial dysfunction is an independent factor responsible for vasospastic angina. Clin Sci (Lond). 101:2001;707-713.
66. Miyata K., Shimokawa H., Yamawaki T., et al. Endothelial vasodilator function is preserved at the spastic/inflammatory coronary lesions in pigs. Circulation. 100:1999;1432-1437.
67. Yasue H., Ogawa H., Okumura K. Coronary artery spasm in the genesis of myocardial ischemia. Am J Cardiol. 63:1989;29E-32E.
68. Rasmussen K., Bagger J.P., Bottzauw J., et al. Prevalence of vasospastic ischaemia induced by the cold pressor test or hyperventilation in patients with severe angina. Eur Heart J. 5:1984;354-361.
69. Motoyama T., Kawano H., Kugiyama K., et al. Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. J Am Coll Cardiol. 32:1998;1672-1679.
70. Hirashima O., Kawano H., Motoyama T., et al. Improvement of endothelial function and insulin sensitivity with vitamin C in patients with coronary spastic angina Possible role of reactive oxygen species . J Am Coll Cardiol. 35:2000;1860-1866.
71. Freedman S.B., Richmond D.R., Kelly D.T. Clinical studies of patients with coronary spasm. Am J Cardiol. 52:1983;67A-71A.
72. Fuller C.M., Raizner A.E., Chahine R.A., et al. Exercise-induced coronary arterial spasm Angiographic demonstration, documentation of ischemia by myocardial scintigraphy and results of pharmacologic intervention . Am J Cardiol. 46:1980;500-506.
73. Specchia G., De Servi S., Falcone C., et al. Coronary arterial spasm as a cause of exercise-induced ST-segment elevation in patients with variant angina. Circulation. 59:1979;948-954.
74. Freedman S.B., Richmond D.R., Kelly D.T. Long-term follow-up of verapamil and nitrate treatment for coronary artery spasm. Am J Cardiol. 50:1982;711-715.
75. Singh B.N., Nademanee K., Figueras J., et al. Hemodynamic and electrocardiographic correlates of symptomatic and silent myocardial ischemia Pathophysiologic and therapeutic implications . Am J Cardiol. 58:1986;3B-10B.
76. Heupler F.A. Jr. Syndrome of symptomatic coronary arterial spasm with nearly normal coronary arteriograms. Am J Cardiol. 45:1980;873-881.
77. Selzer A., Langston M., Ruggeroli C., et al. Clinical syndrome of variant angina with normal coronary arteriogram. N Engl J Med. 295:1976;1343-1347.
78. Kitler M.E. Coronary disease Are there gender differences? Eur Heart J. 15:1994;409-417.
79. Yasue H., Omote S., Takizawa A., et al. Circadian variation of exercise capacity in patients with Prinzmetal's variant angina Role of exercise-induced coronary arterial spasm . Circulation. 59:1979;938-948.
80. Deedwania P.C., Nelson J.R. Pathophysiology of silent myocardial ischemia during daily life. Circulation. 82:1990;1296-1304.
81. Nobuyoshi M., Tanaka M., Nosaka H., et al. Progression of coronary atherosclerosis Is coronary spasm related to progression? J Am Coll Cardiol. 18:1991;904-910.
82. Gould S.E., Hayashi T., Tashiro T., et al. Coronary heart disease and stroke. Atherosclerosis in Japanese men in Hiroshima, Japan and Honolulu, Hawaii. Arch Path. 93:1972;98-102.
83. Trombold J.C., Moellering R.C. Jr, Kagan A. Epidemiological aspects of coronary heart disease and cerebrovascular disease The Honolulu Heart Program . Hawaii Med J. 25:1966;231-234.
84. Sugiishi M., Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation. 87:1993;76-79.
85. Crea F., Von Arnim T., Allwork S.P., et al. Failure of experimental atherosclerosis to sensitize coronary arteries to spasm in hypercholesterolemic rabbits. Am Heart J. 109:1985;491-497.
86. Beltrame J.F., Sasayama S., Maseri A. Racial heterogeneity in coronary artery vasomotor reactivity Differences between Japanese and Caucasian patients . J Am Coll Cardiol. 33:1999;1442-1452.
87. Pristipino C., Beltrame J.F., Finocchiaro M.L., et al. Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation. 101:2000;1102-1108.
88. Sun H., Mohri M., Shimokawa H., et al. Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina. J Am Coll Cardiol. 39:2002;847-851.
89. Maseri A., Davies G.J., Hackett D., et al. Coronary artery spasm and vasoconstriction. Circulation. 81:1990;1983-1991.
90. Kaski J.C., Crea F., Meran D., et al. Local coronary supersensitivity to diverse vasoconstrictive stimuli in patients with variant angina. Circulation. 74:1986;1255-1265.
91. Chierchia S. The role of alpha-adrenergic receptors in the pathogenesis of coronary spasm. Clin Cardiol. 6:1983;496-500.
92. Hillis L.D., Braunwald E.B. Medical progress coronary-artery spasm. N Engl J Med. 299:1978;695-702.
93. Waters D.D., Szlachcic J., Theroux P., et al. Ergonovine testing to detect spontaneous remissions of variant angina during long-term treatment with calcium antagonist drugs. Am J Cardiol. 47:1981;179-183.
94. Heupler F.A. Jr, Proudfit W.L., Razavi M., et al. Ergonovine maleate provocative test for coronary arterial spasm. Am J Cardiol. 41:1978;631-640.
95. Curry R.C. Jr, Pepine C.J., Sabom M.B., et al. Similarities of ergonovine-induced and spontaneous attacks of variant angina. Circulation. 59:1979;307-312.
96. Sueda S., Hashimoto H., Ochi N., et al. New protocol to detect coronary spastic angina without fixed stenosis. Jpn Heart J. 43:2002;307-317.
97. Sueda S., Fukuda H., Watanabe K., et al. Usefulness of accelerated exercise following mild hyperventilation for the induction of coronary artery spasm Comparison with an acetylcholine test . Chest. 119:2001;155-162.
98. Pereira H., Patricio L., Ferreira L., et al. Contribution of Holter monitoring in the diagnosis of a case of Prinzmetal's angina. Rev Port Cardiol. 12:1993;177-183.
99. Muller J.E., Gunther S.J. Nifedipine therapy for Prinzmetal's angina. Circulation. 57:1978;137-139.
100. Schroeder J.S., Rosenthal S., Ginsburg R., et al. Medical therapy of Prinzmetal's variant angina. Chest. 78:1980;231-233.
101. Waters D.D., Theroux P., Szlachcic J., et al. Ergonovine testing in a coronary care unit. Am J Cardiol. 46:1980;922-930.
102. Buxton A., Goldberg S., Hirshfeld J.W., et al. Refractory ergonovine-induced coronary vasospasm Importance of intracoronary nitroglycerin . Am J Cardiol. 46:1980;329-334.
103. Yasue H., Takizawa A., Nagao M., et al. Long-term prognosis for patients with variant angina and influential factors. Circulation. 78:1988;1-9.
104. Schaper J., Mulch J., Winkler B., et al. Ultrastructural, functional, and biochemical criteria for estimation of reversibility of ischemic injury A study on the effects of global ischemia on the isolated dog heart . J Mol Cell Cardiol. 11:1979;521-541.
105. Kloner R.A., Rude R.E., Carlson N.V., et al. Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion Which comes first . Circulation. 62:1980;945-952.
106. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia A delay of lethal cell injury in ischemic myocardium . Circulation. 74:1986;1124-1136.
107. Asimakis G.K., Inners-McBride K., Medellin G., et al. Ischemic preconditioning attenuates acidosis and postischemic dysfunction in isolated rat heart. Am J Physiol. 263:1992;H887-H894.
108. Canty J.M. Jr, Fallavollita J.A. Hibernating myocardium represents a primary downregulation of regional myocardial oxygen consumption distal to a critical coronary stenosis. Basic Res Cardiol. 90:1995;5-8.
109. Shimokawa H., Nagasawa K., Irie T., et al. Clinical characteristics and long-term prognosis of patients with variant angina. A comparative study between western and Japanese populations. Int J Cardiol. 18:1988;331-349.
110. Kawachi Y., Tomoike H., Maruoka Y., et al. Selective hypercontraction caused by ergovine in the canine coronary artery under conditions of induced atherosclerosis. Circulation. 69:1984;441-450.
111. Nakamura M., Tomoike H., Yamamoto Y., et al. Pathophysiology of coronary spasm in miniature swine. 1989.
112. Shimokawa H., Tomoike H., Nabeyama S., et al. Coronary artery spasm induced in miniature swine Angiographic evidence and relation to coronary atherosclerosis . Am Heart J. 110:1985;300-310.
113. Tomoike H. Animal models of coronary spasm and the pathophysiological events in regional vascular hypercontraction. Jpn Circulation J. 49:1985;101-107.
114. Egashira K., Tomoike H., Yamamoto Y., et al. Histamine-induced coronary spasm in regions of intimal thickening in miniature pigs Role of serum cholesterol and spontaneous or induced intimal thickening . Circulation. 74:1986;826-837.
115. Yamamoto Y., Tomoike H., Kobayashi T., et al. Pathogenesis of coronary artery spasm in miniature swine with regional intimal thickening after balloon denudation. Circ Res. 60:1987;113-121.
116. Kandabashi T., Shimokawa H., Miyata K., et al. Inhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1beta. Circulation. 101:2000;1319-1323.
117. Hermsmeyer K., Miyagawa K., Kelley S.T., et al. Reactivity-based coronary vasospasm independent of atherosclerosis in rhesus monkeys. J Am Coll Cardiol. 29:1997;671-680.
118. Minshall R.D., Pavcnik D., Browne D.L., et al. Nongenomic vasodilator action of progesterone on primate coronary arteries. J Appl Physiol. 92:2002;701-708.
119. Minshall R.D., Miyagawa K., Chadwick C.C., et al. In vitro modulation of primate coronary vascular muscle cell reactivity by ovarian steroid hormones. FASEB J. 12:1998;1419-1429.
120. Minshall R.D., Stanczyk F.Z., Miyagawa K., et al. Ovarian steroid protection against coronary artery hyperreactivity in rhesus monkeys. J Clin Endocrinol Metab. 83:1998;649-659.
121. Miyagawa K., Rosch J., Stanczyk F., et al. Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm. Nat Med. 3:1997;324-327.
122. Sato S., Ikegaki I., Asano T., et al. Antiischemic properties of fasudil in experimental models of vasospastic angina. Jpn J Pharmacol. 87:2001;34-40.
123. Hirasawa Y., Sugimoto T., Fukuyama S., et al. Antianginal effects of FR144420, a novel slow nitric oxide-releasing agent. Eur J Pharmacol. 303:1996;55-59.
124. Mizuyama K., Sato S., Okubo N., et al. Spinal anesthesia attenuates myocardial ischemia during coronary artery spasm induced by intraaortic methacholine in rats. Acta Anaesthesiol Scand. 39:1995;802-808.
125. Chang Q., Natelson B.H., Ottenweller J.E., et al. Stress triggers different pathophysiological mechanisms in younger and older cardiomyopathic hamsters. Cardiovasc Res. 30:1995;985-991.
126. Mitsuoka W., Egashira S., Tagawa H., et al. Augmentation of coronary responsiveness to serotonin at the site of X-ray-induced intimal thickening in miniature pigs. Cardiovasc Res. 30:1995;246-254.
127. Chutkow W.A., Pu J., Wheeler M.T., et al. Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 K(ATP) channels. J Clin Invest. 110:2002;203-208.
128. Miki T., Suzuki M., Shibasaki T., et al. Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1. Nat Med. 8:2002;466-472.
129. Ito T., Yasue H., Yoshimura M., et al. Paraoxonase gene Gln192Arg (Q192R) polymorphism is associated with coronary artery spasm. Hum Genet. 110:2002;89-94.
130. Cappelli-Bigazzi M., Nuno D.W., Lamping K.G. Evidence of a role for compounds derived from arginine in coronary response to serotonin in vivo. Am J Physiol. 261:1991;H404-H409.
131. Lamping K.G., Piegors D.J., Benzuly K.H., et al. Enhanced coronary vasoconstrictive response to serotonin subsides after removal of dietary cholesterol in atherosclerotic monkeys. Arterioscler Thromb. 14:1994;951-957.
132. Fukai T., Egashira K., Hata H., et al. Serotonin-induced coronary spasm in a swine model A minor role of defective endothelium-derived relaxing factor . Circulation. 88:1993;. 1992-1930.
133. Gebremedhin D., Koltai M.Z., Pogatsa G., et al. Differential contractile responsiveness of femoral arteries from healthy and diabetic dogs Role of endothelium . Arch Int Pharmacodyn Ther. 288:1987;100-108.
134. Marban E. The surprising role of vascular K(ATP) channels in vasospastic angina. J Clin Invest. 110:2002;153-154.
135. Kugiyama K., Motoyama T., Hirashima O., et al. Vitamin C attenuates abnormal vasomotor reactivity in spasm coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol. 32:1998;103-109.
136. Murrant C.L., Andrade F.H., Reid M.B. Exogenous reactive oxygen and nitric oxide alter intracellular oxidant status of skeletal muscle fibres. Acta Physiol Scand. 166:1999;111-121.
137. Dong H., Waldron G.J., Cole W.C., et al. Roles of calcium-activated and voltage-gated delayed rectifier potassium channels in endothelium-dependent vasorelaxation of the rabbit middle cerebral artery. Br J Pharmacol. 123:1998;821-832.
138. Fukuda Y., Teragawa H., Matsuda K., et al. Tetrahydrobiopterin improves coronary endothelial function, but does not prevent coronary spasm in patients with vasospastic angina. Circ J. 66:2002;58-62.
139. Egashira K., Inou T., Yamada A., et al. Preserved endothelium-dependent vasodilation at the vasospastic site in patients with variant angina. J Clin Invest. 89:1992;1047-1052.
140. Egashira K., Katsuda Y., Mohri M., et al. Basal release of endothelium-derived nitric oxide at site of spasm in patients with variant angina. J Am Coll Cardiol. 27:1996;1444-1449.
141. Beckman J.A., Goldfine A.B., Gordon M.B., et al. Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans. Circulation. 103:2001;1618-1623.
142. Brennan L.A., Steinhorn R.H., Wedgwood S., et al. Increased superoxide generation is associated with pulmonary hypertension in fetal lambs A role for NADPH oxidase . Circ Res. 92:2003;683-691.
143. Cosentino F., Sill J.C., Katusic Z.S. Role of superoxide anions in the mediation of endothelium-dependent contractions. Hypertension. 23:1994;229-235.
144. Lamping K.G. Enhanced contractile mechanisms in vasospasm Is endothelial dysfunction the whole story? Circulation. 105:2002;1520-1522.
145. Lanza G.A., Pedrotti P., Pasceri V., et al. Autonomic changes associated with spontaneous coronary spasm in patients with variant angina. J Am Coll Cardiol. 28:1996;1249-1256.
146. Yasue H., Touyama M., Shimamoto M., et al. Role of autonomic nervous system in the pathogenesis of Prinzmetal's variant form of angina. Circulation. 50:1974;534-539.
147. Choi S.S., Lim Y.J., Bahk J.H., et al. Coronary artery spasm induced by carotid sinus stimulation during neck surgery. Br J Anaesth. 90:2003;391-394.
148. Ricci D.R., Orlick A.E., Cipriano P.R., et al. Altered adrenergic activity in coronary arterial spasm Insight into mechanism based on study of coronary hemodynamics and the electrocardiogram . Am J Cardiol. 43:1979;1073-1079.
149. Hellstrom H.R. The injury-vasospasm hypothesis of ischemic heart disease revisited. Am Heart J. 94:1977;642-648.
150. Goodson A.R., LaMaster T.S., Gutterman D.D. Coronary constrictor pathway from anterior hypothalamus includes neurons in rostroventrolateral medulla. Am J Physiol. 265:1993;R1311-R1317.
151. Miller F.J., Marcus M.L., Brody M.J., et al. Activation in the region of parabrachial nucleus elicits neurogenically mediated coronary vasoconstriction. Am J Physiol. 261:1991;H1585-H1596.
152. Gutterman D.D., Morgan D.A., Miller F.J. Effect of brief myocardial ischemia on sympathetic coronary vasoconstriction. Circ Res. 71:1992;960-969.
153. Nakamura M., Tomoike H., Ootsubo H., et al. Constriction of the epicardial coronary artery induced by α-adrenergic stimulation. Basic Res Cardiol. 76:1981;498-502.
154. Vatner S.F., Pagani M., Manders W.T. Alpha adrenergic vasoconstriction and nitroglycerin vasodilation of large coronary arteries in the conscious dog. J Clin Invest. 65:1980;5-14.
155. Gutterman D.D., Bonham A.C., Arthur J.M., et al. Central neural aspects of coronary flow regulation. Sideman S., Beyar R. Analysis and Simulation of the Cardiac System - Ischemia. 1989;FL CRC Press, Boca Raton.
156. Gutterman D.D., Bonham A.C., Gebhart G.F., et al. Connections between hypothalamus and medullary reticular formation mediate coronary vasoconstriction. Am J Physiol. 259:1990;H917-H924.
157. Arthur J.M., Bonham A.C., Gutterman D.D., et al. Coronary vasoconstriction during stimulation in hypothalamic defense region. Am J Physiol. 260:1991;R335-R345.
158. Gutterman D.D., Arthur J.M., Pardubsky P.D., et al. Role of medullary lateral reticular formation in baroreflex coronary vasoconstriction. Brain Res. 557:1991;202-209.
159. De Boel S.L., Gutterman D.D. Coronary vascular response to the cerebral ischemia reflex. Hypertension. 21:1993;216-221.
160. Van Breemen C., Siegel B. The mechanism of alpha-adrenergic activation of the dog coronary artery. Circ Res. 48:1980;426-429.
161. Verrier R.L., Hagestad E.L., Lown B. Delayed myocardial ischemia induced by anger. Circulation. 75:1987;249-254.
162. Bache R.J., Homans D.C., Dai X.-Z. Adrenergic vasoconstriction limits coronary blood flow during exercise in hypertrophied left ventricle. Am J Physiol. 260:1991;H1489-H1494.
163. Chen D.G., Dai X.-Z., Zimmerman B.G., et al. Postsynaptic alpha1 and alpha2-adrenergic mechanisms in coronary vasoconstriction. J Card Pharmacol. 11:1988;61-67.
164. Buffington C.W., Feigl E.O. Adrenergic coronary vasoconstriction in the presence of coronary stenosis in the dog. Circ Res. 48:1981;416-423.
165. Westby J., Birkeland S., Rynning S.E., et al. α-Adrenergic vasoconstriction in normal and hypoperfused myocardium during sympathetic nerve stimulation. Am J Physiol. 263:1992;H1682-H1688.
166. Yasue H., Touyama M., Kato H., et al. Prinzmetal's variant form of angina as a manifestation of alpha-adrenergic receptor-mediated coronary artery spasm Documentation by coronary arteriography . Am Heart J. 91:1976;148-155.
167. Levene D.L., Freeman M.R. Alpha-adrenoceptor-mediated coronary artery spasm. JAMA. 236:1976;1018-1022.
168. Yasue H. Pathophysiology and treatment of coronary arterial spasm. Chest. 78:1980;216-223.
169. Winniford M.D., Filipchuk N., Hillis L.D. Alpha-adrenergic blockade for variant angina A long-term, double-blind, randomized trial . Circulation. 67:1983;1185-1188.
170. Chierchia S., Davies G., Berkenboom G. Alpha-adrenergic receptors and coronary spasm An elusive link . Circulation. 69:1984;8-14.
171. Robertson R.M., Bernard Y.D., Carr R.K., et al. Alpha-adrenergic blockade in vasotonic angina Lack of efficacy of specific alpha 1-receptor blockade with prazosin . J Am Coll Cardiol. 2:1983;1146-1150.
172. Weber S., Donzeau-Gouge G.P., Chauvaud S., et al. Assessment of plexectomy in the treatment of severe coronary spasm in patients with normal coronary arteries. Am J Cardiol. 51:1983;1072-1075.
173. Dalal J.N., Brinker J.A., Resar J.R. Coronary artery spasm in the transplanted human heart. A case report. Angiology. 47:1996;291-294.
174. Mauritson D.R., Peshock R.M., Winniford M.D., et al. Prinzmetal's variant angina Is it transmitted genetically? Am Heart J. 105:1983;1049.
175. Yoshimura M., Yasue H., Nakayama M., et al. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet. 103:1998;65-69.
176. Nakayama M., Yasue H., Yoshimura M., et al. T-786→C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation. 99:1999;2864-2870.
177. Nakayama M., Yasue H., Yoshimura M., et al. T(-786)→C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with myocardial infarction, especially without coronary organic stenosis. Am J Cardiol. 86:2000;628-634.
178. Heitzer T., Brockhoff C., Mayer B., et al. Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers Evidence for a dysfunctional nitric oxide synthase . Circ Res. 86:2000;E36-E41.
179. Stepp D.W., Ou J., Ackerman A.W., et al. Native LDL and minimally oxidized LDL differentially regulate superoxide anion in vascular endothelium in situ. Am J Physiol Heart Circ Physiol. 283:2002;H750-H759.
180. Horimoto M., Wakisaka A., Takenaka T., et al. Familial evidence of vasospastic angina and possible involvement of HLA-DR2 in susceptibility to coronary spasm. Jpn Circ J. 62:1998;284-288.
181. Meirhaeghe A., Bauters C., Helbecque N., et al. The human G-protein beta3 subunit C825T polymorphism is associated with coronary artery vasoconstriction. Eur Heart J. 22:2001;845-848.
182. Miwa K., Nakagawa K., Suzuki K., et al. Detection of the "midband" lipoprotein in patients with coronary artery spasm. Clin Cardiol. 24:2001;219-224.
183. Nakano T., Osanai T., Tomita H., et al. Enhanced activity of variant phospholipase C-delta1 protein (R257H) detected in patients with coronary artery spasm. Circulation. 105:2002;2024-2029.
184. Mori E., Ikeda H., Ueno T., et al. Vasospastic angina induced by nonsteroidal anti-inflammatory drugs. Clin Cardiol. 20:1997;656-658.
185. Liu Q. Constriction to hypoxia-reoxygenation in isolated mouse coronary arteries Role of endothelium and superoxide . J Appl Physiol. 87:1999;1392-1396.
186. Laurindo F.R., da Luz P.L., Uint L., et al. Evidence for superoxide radical-dependent coronary vasospasm after angioplasty in intact dogs. Circulation. 83:1991;1705-1715.
187. Oltman C.L., Kane N.L., Miller F.J., et al. Reactive oxygen species mediate arachidonic acid-induced dilation in porcine coronary microvessels. Am J Physiol Heart Circ Physiol. 285:2003;H2309-H2315.
188. Koppenol W.H., Moreno J.J., Pryor W.A., et al. Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem Res Toxicol. 5:1992;834-842.
189. Zou M.H., Ullrich V. Peroxynitrite formed by simultaneous generation of nitric oxide and superoxide selectively inhibits bovine aortic prostacyclin synthase. FEBS Lett. 382:1996;101-104.
190. Liu Y., Terata K., Chai Q., et al. Peroxynitrite inhibits Ca2+-activated K+ channel activity in smooth muscle of human coronary arterioles. Circ Res. 91:2002;1070-1076.
191. Laursen J.B., Somers M., Kurz S., et al. Endothelial regulation of vasomotion in apoE-deficient mice Implications for interactions between peroxynitrite and tetrahydrobiopterin . Circulation. 103:2001;1282-1288.
192. Seccombe J.F., Pearson P.J., Schaff H.V. Oxygen radical-mediated vascular injury selectively inhibits receptor-dependent release of nitric oxide from canine coronary arteries. J Thorac Cardiovasc Surg. 107:1994;505-509.
193. Cosentino F., Katusic Z.S. Tetrahydrobiopterin and dysfunction of endothelial nitric oxide synthase in coronary arteries. Circulation. 91:1995;139-144.
194. Hayabuchi Y., Nakaya Y., Matsuoka S., et al. Hydrogen peroxide-induced vascular relaxation in porcine coronary arteries is mediated by Ca2+-activated K+ channels. Heart Vessels. 13:1998;9-17.
195. Barlow R.S., White R.E. Hydrogen peroxide relaxes porcine coronary arteries by stimulating BKCa channel activity. Am J Physiol. 275:1998;H1283-H1289.
196. Oeckler R.A., Kaminski P.M., Wolin M.S. Stretch enhances contraction of bovine coronary arteries via an NAD(P)H oxidase-mediated activation of the extracellular signal-regulated kinase mitogen-activated protein kinase cascade. Circ Res. 92:2003;23-31.
197. Waypa G.B., Marks J.D., Mack M.M., et al. Mitochondrial reactive oxygen species trigger calcium increases during hypoxia in pulmonary arterial myocytes. Circ Res. 91:2002;719-726.
198. Jaimes E.A., Sweeney C., Raij L. Effects of the reactive oxygen species hydrogen peroxide and hypochlorite on endothelial nitric oxide production. Hypertension. 38:2001;877-883.
199. Peterson T.E., Poppa V., Ueba H., et al. Opposing effects of reactive oxygen species and cholesterol on endothelial nitric oxide synthase and endothelial cell caveolae. Circ Res. 85:1999;29-37.
200. Grover A.K., Samson S.E. Effect of superoxide radical on Ca2+ pumps of coronary artery. Am J Physiol. 255:1988;C297-C303.
201. Lounsbury K.M., Hu Q., Ziegelstein R.C. Calcium signaling and oxidant stress in the vasculature. Free Radic Biol Med. 28:2000;1362-1369.
202. Grover A.K., Samson S.E., Robinson S., et al. Effects of peroxynitrite on sarcoplasmic reticulum Ca2+ pump in pig coronary artery smooth muscle. Am J Physiol Cell Physiol. 284:2003;C294-C301.
203. Matsubara T., Nakazawa M., Yoshida Y., et al. Increasing vasoconstrictor response to ergonovine with oxidative injury in canine coronary artery. Coron Artery Dis. 8:1997;1-7.
204. Miwa K., Kishimoto C., Nakamura H., et al. Increased oxidative stress with elevated serum thioredoxin level in patients with coronary spastic angina. Clin Cardiol. 26:2003;177-181.
205. Masumoto A., Mohri M., Shimokawa H., et al. Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation. 105:2002;1545-1547.
206. Shimokawa H., Seto M., Katsumata N., et al. Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm. Cardiovasc Res. 43:1999;1029-1039.
207. Shimokawa H. Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases. J Cardiovasc Pharmacol. 39:2002;319-327.
208. Fukata Y., Amano M., Kaibuchi K. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci. 22:2001;32-39.
209. Batchelor T.J., Sadaba J.R., Ishola A., et al. Rho-kinase inhibitors prevent agonist-induced vasospasm in human internal mammary artery. Br J Pharmacol. 132:2001;302-308.
210. Wickman G., Lan C., Vollrath B. Functional roles of the rho/rho kinase pathway and protein kinase C in the regulation of cerebrovascular constriction mediated by hemoglobin Relevance to subarachnoid hemorrhage and vasospasm . Circ Res. 92:2003;809-816.
211. Sato M., Tani E., Fujikawa H., et al. Involvement of Rho-kinase-mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm. Circ Res. 87:2000;195-200.
212. Brum J.M., Sufan Q., Lane G., et al. Increased vasoconstrictor activity of proximal coronary arteries with endothelial damage in intact dogs. Circulation. 70:1984;1066-1073.
213. Moukarbel G.V., Dakik H.A. Diffuse coronary artery spasm induced by guidewire insertion. J Invasive Cardiol. 15:2003;353-354.
214. Scheinert D., Strnad V., Muller R., et al. High-dose intravascular beta-radiation after de novo stent implantation induces coronary artery spasm. Circulation. 105:2002;1420-1423.
215. Gruberg L., Waksman R. Severe acute coronary spasm following intracoronary radiation for in-stent restenosis A case report . Cardiovasc Radiat Med. 2:2001;138-142.
216. Friedman A.C., Spindola-Franco H., Nivatpumin T. Coronary spasm Prinzmetal's variant angina vs. catheter-induced spasm; refractory spasm vs. fixed stenosis . AJR Am J Roentgenol. 132:1979;897-904.
217. Saff R., Nahhas A., Fink J.N. Myocardial infarction induced by coronary vasospasm after self-administration of epinephrine. Ann Allergy. 70:1993;396-398.
218. Yasue H., Omote S., Takizawa A., et al. Coronary arterial spasm in ischemic heart disease and its pathogenesis. A review. Circ Res. 52:1983;I147-I152.
219. Altura B.M., Altura B.T., Carella A. Ethanol produces coronary vasospasm Evidence for a direct action of ethanol on vascular muscle . Br J Pharmacol. 78:1983;260-262.
220. Wang C.H., Lee C.C., Cherng W.J. Coronary vasospasm induced during isoproterenol head-up tilt test. Am J Cardiol. 80:1997;1508-1510.
221. Guazzi M., Fiorentini C., Polese A., et al. Use of beta-receptor antagonists in spontaneous angina pectoris. Maseri A., Klassen G.A., Lesch M. Primary and Secondary Angina Pectoris. 1978;Grune and Stratton, New York, NY.
222. Bourmayan C., Artigou J.Y., Barrillon A.G., et al. Prinzmetal's variant angina unresponsive to calcium channel-blocking drugs but responsive to combined calcium channel- and beta-blocking drugs. Am J Cardiol. 51:1983;1792-1793.
223. Asanoi H., Kuboki M., Yamamoto M., et al. ST-segment fluctuation during treadmill exercise in patients with angina pectoris. J Electrocardiol. 21:1988;147-153.
224. Tilmant P.Y., Lablanche J.M., Thieuleux F.A., et al. Detrimental effect of propranolol in patients with coronary arterial spasm countered by combination with diltiazem. Am J Cardiol. 52:1983;230-233.
225. Turlapaty P.D., Altura B.M. Propranolol induces contractions of canine small and large coronary arteries. Basic Res Cardiol. 77:1982;68-81.
226. Wendt T., van der Does R., Schrader R., et al. Acute hemodynamic effects of the vasodilating and beta-blocking agent carvedilol in comparison to propranolol. J Cardiovasc Pharmacol. 10:(Suppl 3):1987;S147-S150.
227. Sueda S., Fukuda H., Watanabe K., et al. Magnesium deficiency in patients with recent myocardial infarction and provoked coronary artery spasm. Jpn Circ J. 65:2001;643-648.
228. Hanline M. Jr. Hypomagnesemia causes coronary artery spasm. JAMA. 253:1985;342.
229. Chadda K.D. Clinical hypomagnesemia, coronary spasm and cardiac arrhythmia. Magnesium. 5:1986;47-52.
230. Teragawa H., Kato M., Yamagata T., et al. The preventive effect of magnesium on coronary spasm in patients with vasospastic angina. Chest. 118:2000;1690-1695.
231. Altura B.T., Altura B.M. Endothelium-dependent relaxation in coronary arteries requires magnesium ions. Br J Pharmacol. 91:1987;449-451.
232. Przybojewski J.Z., Heyns M.H. Acute coronary vasospasm secondary to industrial nitroglycerin withdrawal. A case presentation and review. S Afr Med J. 63:1983;158-165.
233. RuDusky B.M. Acute myocardial infarction secondary to coronary vasospasm during withdrawal from industrial nitroglycerin exposure - A case report. Angiology. 52:2001;143-144.
234. Tutkun A., Inanli S., Caymaz O., et al. Cardiotoxicity of 5-flourouracil Two case reports . Auris Nasus Larynx. 28:2001;193-196.
235. Gorgulu S., Celik S., Tezel T. A case of coronary spasm induced by 5-fluorouracil. Acta Cardiol. 57:2002;381-383.
236. Lange R.A., Cigarroa R.G., Yancy C.W. Jr, et al. Cocaine-induced coronary-artery vasoconstriction. N Engl J Med. 321:1989;1557-1562.
237. Majid P.A., Cheirif J.B., Rokey R., et al. Does cocaine cause coronary vasospasm in chronic cocaine abusers? A study of coronary and systemic hemodynamics. Clin Cardiol. 15:1992;253-258.
238. Togna G.I., Graziani M., Russo P., et al. Cocaine toxic effect on endothelium-dependent vasorelaxation An in vitro study on rabbit aorta . Toxicol Lett. 123:2001;43-50.
239. He J., Xiao Y., Zhang L. Cocaine-mediated apoptosis in bovine coronary artery endothelial cells Role of nitric oxide . J Pharmacol Exp Ther. 298:2001;180-187.
240. Mo W., Singh A.K., Arruda J.A., et al. Role of nitric oxide in cocaine-induced acute hypertension. Am J Hypertens. 11:1998;708-714.
241. Pradhan L., Dabisch P.A., Liles J.T., et al. Effect of acute intravenous cocaine administration on endothelium-dependent vasodepressor responses to acetylcholine. J Cardiovasc Pharmacol Ther. 8:2003;43-51.
242. Wilbert-Lampen U., Seliger C., Zilker T., et al. Cocaine increases the endothelial release of immunoreactive endothelin and its concentrations in human plasma and urine Reversal by coincubation with sigma-receptor antagonists . Circulation. 98:1998;385-390.
243. Kalsner S. Cocaine sensitization of coronary artery contractions Mechanism of drug-induced spasm . J Pharmacol Exp Ther. 264:1993;1132-1140.
244. Kolodgie F.D., Virmani R., Cornhill J.F., et al. Increase in atherosclerosis and adventitial mast cells in cocaine abusers An alternative mechanism of cocaine-associated coronary vasospasm and thrombosis . J Am Coll Cardiol. 17:1991;1553-1560.
245. Cannon R.O. III. Myocardial ischemia due to dynamic small vessel coronary artery disease. Int J Cardiol. 7:1985;198-203.
246. Horimoto M., Igarashi K., Takenaka T., et al. Acetylcholine- and ergonovine-induced coronary microvascular spasm reflected by increased coronary vascular resistance and myocardial lactate production. Clin Cardiol. 23:2000;221-225.
247. Masumoto A., Mohri M., Takeshita A. Three-year follow-up of the Japanese patients with microvascular angina attributable to coronary microvascular spasm. Int J Cardiol. 81:2001;151-156.
248. Mohri M., Koyanagi M., Egashira K., et al. Angina pectoris caused by coronary microvascular spasm. Lancet. 351:1998;1165-1169.
249. Lanza G.A., Colonna G., Pasceri V., et al. Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X. Am J Cardiol. 84:1999;854-856. A8.
250. Mohri M., Shimokawa H., Hirakawa Y., et al. Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm. J Am Coll Cardiol. 41:2003;15-19.
251. Saitoh S., Onogi F., Aikawa K., et al. Multiple endothelial injury in epicardial coronary artery induces downstream microvascular spasm as well as remodeling partly via thromboxane A2. J Am Coll Cardiol. 37:2001;308-315.
252. VanBenthuysen K.M., McMurtry I.F., Horwitz L.D. Reperfusion after acute coronary occlusion in dogs impairs endothelium dependent relaxation to acetylcholine and augments contractile reactivity in vitro. J Clin Invest. 79:1987;265-274.
253. Quillen J.E., Sellke F.W., Brooks L.A., et al. Ischemia-reperfusion impairs endothelium-dependent relaxation of coronary microvessels but does not affect large arteries. Circulation. 82:1990;586-594.
254. Fournier J.A., Fernandez-Cortacero J.A.P., Granado C., et al. Familial migraine and coronary artery spasm in two siblings. Clin Cardiol. 9:1986;121-127.
255. Leon-Sotomayor L.A. Cardiac migraine - Report of twelve cases. Angiology. 25:1974;161-171.
256. Nakamura Y., Shinozaki N., Hirasawa M., et al. Prevalence of migraine and Raynaud's phenomenon in Japanese patients with vasospastic angina. Jpn Circ J. 64:2000;239-242.
257. Koh K.K., Kim S.H., Lee K.H., et al. Does prevalence of migraine and Raynaud's phenomenon also increase in Korean patients with proven variant angina? Int J Cardiol. 51:1995;37-46.
258. Pliml W., Kommissari I., Pfaffenrath V., et al. Lack of association of migraine with coronary vasospasm. J Intern Med. 230:1991;455-458.
259. Chinushi M., Kuroe Y., Ito E., et al. Vasospastic angina accompanied by Brugada-type electrocardiographic abnormalities. J Cardiovasc Electrophysiol. 12:2001;108-111.
260. Noda T., Shimizu W., Taguchi A., et al. ST-segment elevation and ventricular fibrillation without coronary spasm by intracoronary injection of acetylcholine and/or ergonovine maleate in patients with Brugada syndrome. J Am Coll Cardiol. 40:2002;1841-1847.
261. Chinushi Y., Chinushi M., Toida T., et al. Class I antiarrhythmic drug and coronary vasospasm-induced T wave alternans and ventricular tachyarrhythmia in a patient with Brugada syndrome and vasospastic angina. J Cardiovasc Electrophysiol. 13:2002;191-194.
262. Phull P.S., Collins C.E., Norell M.S., et al. Variant angina in thyrotoxicosis. Br J Clin Pract. 47:1993;17-18.
263. Nakano T., Konishi T., Takezawa H. Vasospastic angina in thyrotoxicosis - Case reports. Angiology. 38:1987;717-722.
264. Moliterno D., DeBold C.R., Robertson R.M. Case report Coronary vasospasm - Relation to the hyperthyroid state . Am J Med Sci. 304:1992;38-42.
265. DeTommasi A., Rogge S., Houghton J.L. Refractory vasomotor angina in subclinical hyperthyroidism demonstrating focal and segmental coronary vasoconstriction. J Invasive Cardiol. 15:2003;289-292.
266. Kawasaki K., Seki K., Miyazawa I., et al. Effects of diltiazem and nitroglycerin on prostaglandin F2 alpha-induced periodic contractions of isolated human coronary arteries. Jpn Circ J. 49:1985;145-154.
267. Ginsburg R., Bristow M.R., Harrison D.C., et al. Studies with isolated human coronary arteries some general observations, potential mediators of spasm, role of calcium antagonists. Chest. 78:1980;180-186.
268. Sueda S., Kohno H., Fukuda H., et al. Limitations of medical therapy in patients with pure coronary spastic angina. Chest. 123:2003;380-386.
269. Shimokawa H., Morishige K., Miyata K., et al. Long-term inhibition of Rho-kinase induces a regression of arteriosclerotic coronary lesions in a porcine model in vivo. Cardiovasc Res. 51:2001;169-177.
270. Sueda S., Saeki H., Otani T., et al. Investigation of the most effective provocation test for patients with coronary spastic angina Usefulness of accelerated exercise following hyperventilation . Jpn Circ J. 63:1999;85-90.
271. Morishige K., Shimokawa H., Eto Y., et al. Adenovirus-mediated transfer of dominant-negative rho-kinase induces a regression of coronary arteriosclerosis in pigs in vivo. Arterioscler Thromb Vasc Biol. 21:2001;548-554.
272. Shimizu H., Lee J.D., Ogawa K.B., et al. Efficacy of denopamine, a beta 1 adrenoceptor agonist, in preventing coronary artery spasm. Jpn Circ J. 57:1993;175-182.
273. Hirai N., Kawano H., Hirashima O., et al. Insulin resistance and endothelial dysfunction in smokers Effects of vitamin C . Am J Physiol Heart Circ Physiol. 279:2000;H1172-H1178.
274. Gokce N., Keaney J.F. Jr, Frei B., et al. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation. 99:1999;3234-3240.
275. Khatri S., Webb J.G., Carere R.G., et al. Stenting for coronary artery spasm. Catheter Cardiovasc Interv. 56:2002;16-20.
276. Endo M., Kanda I., Hosoda S., et al. Prinzmetal's variant form of angina pectoris. Re-evaluation of mechanisms. Circulation. 52:1975;33-37.